Objective
The increase of multidrug-resistant (MDR) strains of
Acinetobacter baumannii
(
A. baumannii
), especially carbapenem-resistant strains, is challenging for treating infections. This study investigated the antibiotic resistance pattern and frequency of carbapenem resistance genes (oxacillinase and metallo-beta-lactamase) in
A. baumannii.
Results
In this study, 100 bacterial isolates were collected from clinical samples from different hospitals in Isfahan, central of Iran. Of 100 samples of bloodstream, urine, cerebrospinal fluid (CSF), wound, and trachea, 60 bacteria were identified as
A. baumannii
. The results showed that 100% of the selected isolates were resistant to cefotaxime, ceftazidime, ciprofloxacin, piperacillin-tazobactam, and meropenem. Based on the antibiotic resistance pattern, 25 isolates were chosen for PCR analysis targeting
bla
OXA−51
,
bla
OXA−23
, bla
OXA−58
,
bla
NDM
,
bla
IMP
, and
bla
VIM
genes PCR results revealed that among the selected isolates, 15 (60.0%) harbored the
bla
OXA−23
gene, 23 (92.0%) contained the
bla
OXA−51
gene, and 1 (4.0%) isolate carried the
bla
NDM
gene. Based on MLST analysis, two colistin-resistant
Acinetobacter baumannii
isolates were categorized as ST2. The ST2 clone represents the predominant sequence type within the CC2 or international clone two. The results showed that the best antibiotic against isolates was colistin.
bla
OXA−51
and
bla
OXA−23
genes (oxacillinase genes) were dominant genes, but
bla
IMP
and
bla
OXA−58
were not local carbapenem resistant genes in Isfahan.
Supplementary Information
The online version contains supplementary material available at 10.1186/s13104-024-07047-5.